IRIS
BELLOTTI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.169
AS - Asia 6.248
EU - Europa 5.239
SA - Sud America 789
Continente sconosciuto - Info sul continente non disponibili 278
AF - Africa 174
OC - Oceania 15
Totale 22.912
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.776
CN - Cina 3.097
SG - Singapore 1.339
IE - Irlanda 1.113
HK - Hong Kong 693
IT - Italia 679
UA - Ucraina 619
BR - Brasile 598
FI - Finlandia 557
RU - Federazione Russa 549
DE - Germania 504
VN - Vietnam 460
FR - Francia 344
GB - Regno Unito 310
SE - Svezia 271
CA - Canada 154
IN - India 154
BD - Bangladesh 95
ZA - Sudafrica 68
AR - Argentina 64
PL - Polonia 58
MX - Messico 55
TR - Turchia 52
JP - Giappone 46
BE - Belgio 39
IQ - Iraq 39
NL - Olanda 39
IL - Israele 37
ES - Italia 36
ID - Indonesia 32
CO - Colombia 31
PK - Pakistan 27
HN - Honduras 26
VE - Venezuela 26
EC - Ecuador 22
JM - Giamaica 22
MA - Marocco 22
CR - Costa Rica 21
GT - Guatemala 21
PH - Filippine 20
SV - El Salvador 19
TT - Trinidad e Tobago 19
UZ - Uzbekistan 19
PR - Porto Rico 18
TN - Tunisia 18
SA - Arabia Saudita 17
KE - Kenya 16
CZ - Repubblica Ceca 15
GP - Guadalupe 15
SC - Seychelles 14
CW - ???statistics.table.value.countryCode.CW??? 13
JO - Giordania 13
AT - Austria 12
CL - Cile 12
BO - Bolivia 11
NI - Nicaragua 11
PE - Perù 11
PY - Paraguay 11
IR - Iran 10
KR - Corea 10
LT - Lituania 10
TH - Thailandia 10
DK - Danimarca 9
EG - Egitto 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
HR - Croazia 8
MY - Malesia 8
EE - Estonia 7
GR - Grecia 7
HU - Ungheria 7
KG - Kirghizistan 7
LV - Lettonia 7
MU - Mauritius 7
AZ - Azerbaigian 6
NZ - Nuova Zelanda 6
OM - Oman 6
PT - Portogallo 6
RO - Romania 6
AL - Albania 5
BB - Barbados 5
CH - Svizzera 5
SN - Senegal 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KW - Kuwait 4
LB - Libano 4
MD - Moldavia 4
NP - Nepal 4
RS - Serbia 4
BG - Bulgaria 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
ET - Etiopia 2
Totale 22.614
Salva come PNG Salva come JPEG
Città #
Dublin 1.111
San Jose 1.040
Chandler 1.034
Ashburn 775
Jacksonville 757
Singapore 682
Hong Kong 671
Nanjing 665
Dallas 595
Beijing 545
Council Bluffs 535
Boardman 330
Nanchang 277
Princeton 222
Shenyang 202
Wilmington 201
Los Angeles 187
Hebei 185
Lauterbourg 185
Lawrence 184
Ann Arbor 176
Changsha 174
Helsinki 161
Medford 154
Ho Chi Minh City 147
Jiaxing 135
New York 129
Milan 113
Hanoi 110
Tianjin 106
Munich 104
Buffalo 101
Hangzhou 95
Santa Clara 95
Moscow 89
Shanghai 78
Woodbridge 75
Redondo Beach 71
São Paulo 67
Johannesburg 56
Orem 54
Turku 51
Pavia 46
Rome 46
Chicago 44
Verona 43
The Dalles 42
Brooklyn 40
Falls Church 40
Tokyo 39
Toronto 39
Brussels 38
Warsaw 38
Montreal 37
Chennai 35
Denver 34
Atlanta 31
Frankfurt am Main 31
Houston 31
Naples 31
Norwalk 30
Phoenix 30
Piscataway 30
London 27
Seattle 27
Fairfield 26
Da Nang 23
San Francisco 23
Stockholm 23
Charlotte 21
Columbus 20
Haiphong 20
Mexico City 20
North Bergen 20
Rio de Janeiro 20
Ankara 19
Guangzhou 19
Jinan 19
Belo Horizonte 18
Falkenstein 18
San Salvador 18
Washington 18
Bologna 17
Boston 17
Kingston 17
Amsterdam 16
Baghdad 16
Mumbai 16
Tashkent 16
Auburn Hills 15
Florence 14
Guatemala City 14
Queens 14
Curitiba 13
Istanbul 13
Manchester 13
Nuremberg 13
San José 13
Willemstad 13
Biên Hòa 12
Totale 14.160
Salva come PNG Salva come JPEG
Nome #
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 244
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 220
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 219
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 202
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 185
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis 174
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 170
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 163
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 163
Biological activity and pathological implications of misfolded proteins. 162
Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. 159
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 154
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. 152
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 151
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy 151
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 149
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 148
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 148
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 146
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 144
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 144
WALDENSTROM'S HYPERGLOBULINEMIC PURPURA IN HLA IDENTICAL SISTERS. 143
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 143
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 141
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 141
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 141
Biochimica Applicata 141
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 141
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 140
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 140
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 138
“Separation and quantification of two beta2-microglobulin isoforms”. 138
AMYLOIDOSIS AL 136
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 136
Capillary electrophoresis investigation of a partially unfolded conformation of Beta 2-microglobulin. 136
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 136
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 135
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 135
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 133
Development of a method to screen potential ligands of amyloidogenic proteins 132
C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis 132
beta 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation 131
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 131
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers. 130
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 130
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 130
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 129
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 129
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 129
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 127
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 126
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 126
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 125
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 125
Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component 125
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid 125
Amyloid persistence in decellularized liver: Biochemical and histopathological characterization 125
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 123
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 121
Cerebrospinal fluid ferritin in human disease. 121
Cinetiche di refolding e studi di affinità mediante elettroforesi capillare: effetto di ligandi di interesse farmaceutico sulla conformazione della Beta 2-microglobulina 120
CHRONIC LYMPHOCYTIC LEUKAEMIA OR IDIOPATHIC COLD HAEMAGGLUTININ DISEASE? A DILEMMA RAISED BY AN ERRONEOUS ELECTRONIC CELL COUNT 119
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 119
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 119
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine 119
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 118
USE OF A MONOCLONAL ANTIBODY AGAINST HUMAN HEART FERRITIN FOR EVALUATING ACIDIC FERRITIN CONCENTRATION IN HUMAN SERUM 117
Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implication 117
A Narrative Review of the Role of Transthyretin in Health and Disease 117
Targeting C-reactive protein for the treatment of cardiovascular disease. 116
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 115
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. 114
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. 113
Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- And Long-Distance Conformational Changes 113
Current concepts on the pathogenisis of systemic amyloidosis 112
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 112
Proteomics of beta2-microglobulin amyloid fibrils. 112
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 112
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils 112
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 111
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. 111
DETECTION OF FRAGMENTS OF BETA2-MICROGLOBULIN IN AMYLOID FIBRILS 111
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 110
Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability 110
Conformational transition and cellular toxicity by amyloidogenic proteins 109
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin 109
Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity 109
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 109
PLASMA FERRITIN DETERMINATION AS A DIAGNOSTIC TOOL 108
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 107
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 107
Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity 107
Nanobodies against beta2-microglobulin. 106
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 106
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile 106
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly. 105
Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro 105
Misidentification of transthyretin and immunoglobulin variants by proteomics due to methyl lysine formation in formalin-fixed paraffin-embedded amyloid tissue 105
Human wild-type and D76N β2-microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans 104
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 104
Totale 13.169
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022859 0 0 0 0 28 56 18 64 58 36 132 467
2022/20233.045 365 239 26 219 315 280 0 160 1.307 20 64 50
2023/2024968 136 202 40 57 104 222 12 48 8 41 69 29
2024/20252.973 71 240 78 94 76 111 113 222 779 91 336 762
2025/20267.115 536 499 823 782 842 326 1.394 245 602 573 205 288
2026/20272.532 258 386 531 904 453 0 0 0 0 0 0 0
Totale 22.912